DuvergerA, JacksonR. J,
van GinkelF. W.
7 other authors2006; Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens. J Immunol 176:1776–1783[CrossRef]
HathewayC. L, McCroskeyL. M, LombardG. L, DowellV. R.Jr1981; Atypical toxin variant of Clostridium botulinum type B associated with infant botulism. J Clin Microbiol 14:607–611
LeeJ. C, YokotaK, ArimitsuH. 7 other authors2005; Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin. Microbiology 151:3739–3747[CrossRef]
OgumaK, AguiT, SyutoB, KimuraK, IidaH, KuboS.
1982; Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum . Infect Immun 38:14–20
OgumaK, MurayamaS, SyutoB, IidaH, KuboS.
1984; Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies. Infect Immun 43:584–588
SunH. X.
2006; Adjuvant effect of Achyranthes bidentata saponins on specific antibody and cellular response to ovalbumin in mice. Vaccine 24:3432–3439[CrossRef]
SuzukiT, WatanabeT, MutohS, HasegawaK, KouguchiH, SaganeY, FujinagaY, OgumaK, OhyamaT.
2005; Characterization of the interaction between subunits of the botulinum toxin complex produced by serotype D through tryptic susceptibility of the isolated components and complex forms. Microbiology 151:1475–1483[CrossRef]
VertievY. V, ZdanovskyA. G, ShevelevA. B, BorinskayaS. A, GeningE. L, MartinT, IvanovP. A, YankovskyN. K.
2001; Recombinant Listeria strains producing the nontoxic L-chain of botulinum neurotoxin A in a soluble form. Res Microbiol 152:563–567[CrossRef]